In this comprehensive article, we lay down insights on the gut-lung axis, a detailed perspective on the existing correlation between gut microbiome and lung cancer, with a special focus on the role of pleiotropic cytokines, IL-6 and IL-17, in regulating this axis in NSCLC development (Figure 1). The gene discussed is IL6; the disease is non-small cell lung carcinoma.